Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Centessa Pharmaceuticals plc ADR shares valued at $510,000 were sold by Weinhoff Gregory M on Sep 10 ’24. At $17.00 per share, Weinhoff Gregory M sold 30,000 shares. The insider’s holdings dropped to 223,369 shares worth approximately $3.54 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, SAHA SAURABH sold 175,000 shares, netting a total of over 2,891,822 in proceeds. Following the sale of shares at $16.52 each, the insider now holds 776,924 shares.
Before that, SAHA SAURABH had added 175,000 shares to its account. In a trade valued at $2,891,822, the Officer bought Centessa Pharmaceuticals plc ADR shares for $16.52 each.
As published in their initiating research note from B. Riley Securities on September 19, 2024, Centessa Pharmaceuticals plc ADR [CNTA] has been a Buy and the price target has been revised to $33. Analysts at Oppenheimer started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid July. As of November 15, 2023, Jefferies has increased its “Hold” rating to a “Buy” for CNTA. Earlier on October 26, 2023, Morgan Stanley upgraded its rating. Their new recommendation was “an Equal-weight” for CNTA stock which previously was a “an Underweight”.
Analyzing CNTA Stock Performance
During the last five days, there has been a surge of approximately 4.97%. Over the course of the year, Centessa Pharmaceuticals plc ADR shares have jumped approximately 99.12%. Shares of the company reached a 52-week high of $17.59 on 09/13/24 and a 52-week low of $6.65 on 01/11/24. A 50-day SMA is recorded $12.20, while a 200-day SMA reached $9.93. Nevertheless, trading volume fell to 0.81 million shares from 0.62 million shares the previous day.
Support And Resistance Levels for Centessa Pharmaceuticals plc ADR (CNTA)
According to the 24-hour chart, there is a support level at 15.50, which, if violated, would cause prices to drop to 15.14. In the upper region, resistance lies at 16.50. The next price resistance is at 17.14. RSI (Relative Strength Index) is 63.09 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.93, which suggests the price will decrease in the coming days. Percent R is at 37.42%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
